CAPPABIANCA, LUCIA ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.017
EU - Europa 1.763
AS - Asia 1.708
SA - Sud America 243
AF - Africa 27
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.769
Nazione #
US - Stati Uniti d'America 2.969
SG - Singapore 715
RU - Federazione Russa 408
CN - Cina 406
IE - Irlanda 353
BR - Brasile 210
DE - Germania 210
IT - Italia 197
TR - Turchia 171
HK - Hong Kong 163
VN - Vietnam 144
GB - Regno Unito 119
SE - Svezia 103
UA - Ucraina 96
FI - Finlandia 82
FR - Francia 72
IN - India 29
CA - Canada 27
CZ - Repubblica Ceca 26
AT - Austria 17
PL - Polonia 15
MX - Messico 14
NL - Olanda 14
ZA - Sudafrica 14
BE - Belgio 12
ES - Italia 12
AR - Argentina 11
BD - Bangladesh 11
JP - Giappone 11
KR - Corea 10
EC - Ecuador 7
UY - Uruguay 7
UZ - Uzbekistan 7
IQ - Iraq 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EU - Europa 5
EG - Egitto 4
KZ - Kazakistan 4
PH - Filippine 4
BY - Bielorussia 3
DZ - Algeria 3
ID - Indonesia 3
PA - Panama 3
PK - Pakistan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
GN - Guinea 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 6.769
Città #
Singapore 431
Jacksonville 365
Dublin 353
Chandler 348
San Jose 326
Dallas 268
Ashburn 184
Hong Kong 159
Boardman 124
Santa Clara 124
New York 95
The Dalles 78
Nanjing 77
Izmir 76
Council Bluffs 73
Beijing 71
Wilmington 64
Munich 60
Moscow 55
San Mateo 53
Lawrence 46
Princeton 46
Ann Arbor 41
Dearborn 39
Ho Chi Minh City 39
Lauterbourg 38
L'aquila 35
Los Angeles 32
Milan 31
Nanchang 30
Hanoi 29
Brno 24
Turku 23
Frankfurt am Main 22
Shenyang 22
São Paulo 22
Dong Ket 20
Helsinki 18
Rome 17
Seattle 17
Verona 17
Orem 16
Tianjin 16
Falls Church 15
Hefei 15
Hebei 14
Warsaw 14
Mountain View 13
Nuremberg 13
Brooklyn 12
Brussels 12
Columbus 12
Johannesburg 12
L’Aquila 12
Woodbridge 12
Boston 11
Chennai 11
Denver 11
Stockholm 11
Tokyo 11
Bremen 10
Toronto 10
Jiaxing 9
Jinan 9
London 9
Montreal 9
Phoenix 9
Shanghai 9
Des Moines 8
Philadelphia 8
Poplar 8
Amsterdam 7
Ankara 6
Atlanta 6
Auburn Hills 6
Falkenstein 6
Guangzhou 6
Impruneta 6
Kitzingen 6
Kunming 6
Montevideo 6
Rio de Janeiro 6
Salvador 6
Tashkent 6
Vienna 6
West Jordan 6
Biên Hòa 5
Curitiba 5
Da Nang 5
Houston 5
Mexico City 5
Ningbo 5
Norwalk 5
Querétaro 5
Recife 5
San Francisco 5
Washington 5
Almaty 4
Brasília 4
Changsha 4
Totale 4.491
Nome #
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 182
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 172
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 168
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 160
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 154
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 144
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 143
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 140
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 140
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 138
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 138
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 137
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 134
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 133
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen 133
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 133
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 132
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 131
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 130
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 128
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 125
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 124
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 122
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 119
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 116
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 114
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 112
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 112
IN VIVO ANALYSIS OF THE MODEL TYROSINE AMINOTRANSFERASE GENE REVEALS MULTIPLE SEQUENTIAL STEPS IN GLUCOCORTICOID RECEPTOR ACTION 111
Alternative TrkA splicing and neuroblastoma 111
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 110
TrkAIII expression in the thymus 110
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 110
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 109
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 109
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 107
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 107
Nature of the accessible chromatin at a glucocorticoid-responsive enhancer 107
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 104
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 104
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 102
Thioredoxin inhibits microvascular endothelial capillary tubule formation 102
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 101
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 101
Alternative TrkA splicing and Cancer 99
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 95
Alternative TrkAIII splicing and Cancer 94
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 94
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 88
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 88
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 88
Genomic footprinting using nucleases 85
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 84
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 82
The alternative TrkAIII splice variant expressed by human neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 80
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 76
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 65
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 48
Jurkat T-Cell Antigen-Independent Elimination of PMA-Activated Neuroblastoma Cells Is Triggered by CCL2/CCR2, Depends Upon Lipid Raft LFA1/ICAM1 Immune Synapses, Is Mediated by m-TRAIL and Is Augmented by the TrkAIII Oncoprotein 30
null 5
Totale 6.884
Categoria #
all - tutte 27.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 81 30
2021/2022293 21 22 35 14 17 9 9 20 15 8 24 99
2022/2023993 61 70 20 115 91 102 3 44 440 3 23 21
2023/2024284 34 11 25 25 13 89 1 3 5 10 7 61
2024/20251.288 39 17 103 69 154 111 198 97 224 85 100 91
2025/20262.468 115 240 207 344 287 165 366 69 226 349 100 0
Totale 6.884